{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:16:32Z","timestamp":1788833792630,"version":"build-2803163510"},"reference-count":16,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0228617","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T13:30:38Z","timestamp":1581427838000},"page":"e0228617","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5675-945X","authenticated-orcid":true,"given":"Myla D.","family":"Goldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Woong","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Stuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"pone.0228617.ref001","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"R Gold","year":"2012","journal-title":"N Engl J Med"},{"key":"pone.0228617.ref002","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","article-title":"Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis","volume":"367","author":"RJ Fox","year":"2012","journal-title":"N Engl J Med"},{"key":"pone.0228617.ref003","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/1352458514559299","article-title":"Dimethyl fumarate associated lymphopenia in clinical practice","volume":"21","author":"EE Longbrake","year":"2015","journal-title":"Mult Scler"},{"key":"pone.0228617.ref004","article-title":"Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance","volume":"1","author":"EE Longbrake","year":"2015","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"pone.0228617.ref005","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s40264-016-0461-6","article-title":"Treatment-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Comprehensive Review of Current Evidence and Future Needs","volume":"39","author":"E D'Amico","year":"2016","journal-title":"Drug Saf"},{"key":"pone.0228617.ref006","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.autrev.2017.01.013","article-title":"Neutrophil perversion in demyelinating autoimmune diseases: Mechanisms to medicine","volume":"16","author":"CS Casserly","year":"2017","journal-title":"Autoimmun Rev"},{"key":"pone.0228617.ref007","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1172\/JCI72151","article-title":"Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE","volume":"124","author":"H Chen","year":"2014","journal-title":"J Clin Invest"},{"key":"pone.0228617.ref008","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1212\/NXI.0000000000000076","article-title":"Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate","volume":"2","author":"CM Spencer","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"pone.0228617.ref009","article-title":"Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients","volume":"15","author":"MQ Lou","year":"2015","journal-title":"Bmc Endocr Disord"},{"key":"pone.0228617.ref010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.dsx.2014.04.009","article-title":"Usefulness of the neutrophil-to-lymphocyte ratio to prediction of type 2 diabetes mellitus in morbid obesity","volume":"9","author":"H Yilmaz","year":"2015","journal-title":"Diabetes Metab Syndr"},{"key":"pone.0228617.ref011","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/EJE-15-0176","article-title":"Neutrophil: lymphocyte ratio is positively related to type 2 diabetes in a large-scale adult population: a Tianjin Chronic Low-Grade Systemic Inflammation and Health cohort study","volume":"173","author":"XY Guo","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"pone.0228617.ref012","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.msard.2017.10.009","article-title":"The neutrophil-to-lymphocyte ratio as disease actvity marker in multiple sclerosis and optic neuritis","volume":"18","author":"AK Bisgaard","year":"2017","journal-title":"Mult Scler Relat Dis"},{"key":"pone.0228617.ref013","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.1212\/NXI.0000000000000378","article-title":"Glucocorticoid-associated blood glucose response and MS relapse recovery","volume":"4","author":"M Goldman","year":"2017","journal-title":"Neuroinflammation and Neurimmunology"},{"key":"pone.0228617.ref014","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.msard.2018.02.007","article-title":"Dimethyl fumarate in a patient with multiple sclerosis and type 1 diabetes mellitus: The importance of keonuria","volume":"21","author":"W Krystanek","year":"2018","journal-title":"mult Scler Relat Disord"},{"key":"pone.0228617.ref015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"CH Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"pone.0228617.ref016","doi-asserted-by":"crossref","first-page":"486","DOI":"10.7326\/0003-4819-146-7-200704030-00004","article-title":"Prevalence of Neutropenia in the U.S. Population: Age, Sex, Smoking Status, and Ethnic Differences","volume":"146","author":"M Hsieh","year":"2007","journal-title":"Annals of Internal Medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T13:30:48Z","timestamp":1581427848000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228617"}},"subtitle":[],"editor":[{"given":"Jian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0228617","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]}}}